Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia-Reference-Cited by-同舟云学术

Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia

Published:2019-10 Issue: Volume:85 Page:106197
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

DeAngelo Daniel J.,Walker Alison R.,Schlenk Richard F.,Sierra Jorge,Medeiros Bruno C.,Ocio Enrique M.,Röllig Christoph,Strickland Stephen A.,Thol Felicitas,Valera Sue-zette,Dasgupta Kohinoor,Berkowitz Noah,Stuart Robert K.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. Acute myeloid leukemia;Dohner;N. Engl. J. Med.,2015

2. Acute myeloid leukaemia;Estey;Lancet,2006

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood,2010

4. A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia;Deangelo;Leuk. Res.,2014

5. Age and acute myeloid leukemia;Appelbaum;Blood,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Histone Deacetylase Inhibitor in Acute Myeloid Leukemia;PROG BIOCHEM BIOPHYS;2024

2. Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review;Frontiers in Oncology;2024-02-21

3. Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax;Biochemical Pharmacology;2024-02

4. A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment;Pharmaceuticals;2023-11-15

5. Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-03